Shu-ichi Ueno

Prof. Shu-ichi Ueno

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1991 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
THTakashi Hineno
Takashi Hineno
ASAkira Sano
Akira Sano
KKKeiji Kondoh
Keiji Kondoh
SUShu-ichi Ueno
Shu-ichi Ueno
YKYasuo Kakimoto
Yasuo Kakimoto
KYKen-Ichi Yoshida
Ken-Ichi Yoshida

1 December 1989 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ASAkira Sano
Akira Sano
THTakashi Hineno
Takashi Hineno
TMTatsuo Mizuno
Tatsuo Mizuno
KKKeiji Kondoh
Keiji Kondoh
SUShu-ichi Ueno
Shu-ichi Ueno
KIKoji Inui
Koji Inui

1 December 1992 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
SUShu-ichi Ueno
Shu-ichi Ueno
ASAkira Sano
Akira Sano
KKKazuhiko Kotani
Kazuhiko Kotani
KKKeiji Kondoh
Keiji Kondoh
YKYasuo Kakimoto
Yasuo Kakimoto

26 January 2005 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
YTYuko Tomemori
Yuko Tomemori
MIMio Ichiba
Mio Ichiba
AKAkira Kusumoto
Akira Kusumoto
EMEmiko Mizuno
Emiko Mizuno
DSDaisuke Sato
Daisuke Sato
ASAkira Sano
Akira Sano

1 January 2008 in Annals of Medicine
Verified
Journal Article
Closed access
JIJunichi Iga
Junichi Iga
SUShu-ichi Ueno
Shu-ichi Ueno
TOTetsuro Ohmori
Tetsuro Ohmori
Depression is a disorder not only in the central nervous system (CNS), but also in the systemic neuroendocrine, autonomic nervous, and immune systems. The changes in these systems have been widely studied in depression by using serum proteins because they are easily and repetitively studied before, during, and after treatment. Recently, gene expressions in the peripheral blood leukocytes have been used to assess the depressive changes in the CNS by DNA microarrays and/or real-time polymerase chain reaction (PCR) methods. These studies will give us clues to assess depression because circulating peripheral leukocytes are influenced by systems that underlie depression, and the quantification of mRNAs in them is methodologically precise and easier than that of protein. In this paper, we review the studies on the leukocyte gene expression, including our own, and discuss the limitations and strengths of the current gene expression-based molecular assessment of depression by the leukocyte mRNA expression.

18 August 2011 in Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
SMSatsuki Mori
Satsuki Mori
MNMasayuki Nakamura
Masayuki Nakamura
TYTakeshi Yasuda
Takeshi Yasuda
SUShu-ichi Ueno
Shu-ichi Ueno
SKSunao Kaneko
Sunao Kaneko
ASAkira Sano
Akira Sano
Benign adult familial myoclonic epilepsy (BAFME), alternatively named familial adult myoclonic epilepsy 1/familial cortical myoclonic tremor with epilepsy 1 (FAME1/FCMTE1), is a hereditary epileptic syndrome characterized by autosomal dominant inheritance, adult-onset tremulous hand movement, myoclonus, infrequent epileptic seizure and non-progressive course without cerebellar ataxia and dementia. We previously reported evidence for linkage of BAFME to the region between D8S1784 and D8S1694 on chromosome 8q. Subsequently, other research groups reported mapping of the same clinical syndrome to different chromosomal loci, 2p and 5p, in Italian (FAME2/FCMTE2) and French (FAME3/FCMTE3) families, respectively. In this study, we performed a genome-wide linkage analysis using 10K single-nucleotide polymorphism arrays and additional microsatellite markers to reconfirm the BAFME-linked region. The BAFME-linked region was mapped to 7.16 Mb spanned by rs1898287 and rs2891799 on chromosomes 8q23.3–8q24.13 with a maximum two-point logarithm of odds score of 6.0 for the marker rs1021897. Sequence analysis and copy-number variant analysis of all 38 genes localized in the candidate region were performed, but no pathogenic mutation was identified. We conclude that the etiology of BAFME remains to be solved, and further genetic studies, which may require analysis in non-coding regions of a gene, introns or intergenic spacer regions, are necessary to reveal its unknown mutations.